Federal Prosecutors Target Merck, J&J and Endo for PMB Contract Info

May 11, 2016

Wall Street Journal

According to the Wall Street Journal, federal prosecutors are investigating drug manufacturers' contracts with companies that manage prescription benefits in the United States.

The U.S. Attorney’s Office for the Southern District of New York has requested information from at least three drug companies: Johnson & Johnson, Merck & Co. and Endo International, noting recent company filings with the U.S. Securities and Exchange Commission.

The article said investigative demands included information about contracts with pharmacy-benefit managers (PBMs), which administer drug benefits for employers and health insurers. Read the full WSJ story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments